HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

Imaging technologies for retinal biomarkers in Alzheimer’s disease

Andrew Kadis from Cambridge Vision Technology guides us through imaging technologies for retinal biomarkers in Alzheimer’s disease.

An emerging environmental health concern: Impacts of air pollution on the brain

Anthony S. Wexler and Pamela J. Lein from the University of California share their expert views on the impacts of air pollution on the...

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are...

Alzheimer’s as a spectrum disorder: The promise of precision medicine

Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.

PET imaging of neurodegenerative diseases

Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging

Alzheimer’s disease: Treatment failures and future directions

A paradigm shift is needed if researchers are to find a successful for treatment for Alzheimer’s disease, argues Ai-Ling Lin of the Lin Brain Lab.

Dementia as a progressive condition

The Alzheimer's Society in the UK provides a fascinating glimpse into the most dementia as a progressive condition and its common forms

Can a new light-based therapy help with Alzheimer’s disease?

Prof Michael R Hamblin of the Wellman Center for Photomedicine at Massachusetts General Hospital discusses a new light-based therapy for Alzheimer’s disease

Finding effective treatments for vascular dementia

Dr Doug Brown, Director of Research, Alzheimer’s Society provides details on the research into vascular dementia and explains why more work is needed Vascular dementia...

Tackling cognitive decline in Alzheimer’s disease

Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition Alzheimer’s disease...

Pharmacogenomics of polypharmacy in Alzheimer’s disease

Ramón Cacabelos of EuroEspes Biomedical Research Center details how the incorporation of pharmacogenomics to treat Alzheimer’s patients is crucial

Dementia research: Translating knowledge into new treatments

Chief Executive Hilary Evans highlights how Alzheimer’s Research UK is helping advance dementia research, but warns there is still more to be done

Italy’s ageing population and the healthcare challenge

Open Access Government examines some of the statistics around Italy's ageing population, related health challenges, and policy action to address the issue Italy is currently...

Making personal budgets dementia friendly

A sea change is needed among local authorities to make personal budgets dementia friendly, argues George McNamara of the Alzheimer’s Society People with dementia and...

The role of small heat shock proteins in human diseases

Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases Cells are frequently exposed to...

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are...

Nanoimaging to cure Alzheimer’s disease

Background of Alzheimer’s disease Alzheimer’s disease (AD) is one of the most devastating neurodegenerative disorders affecting more than 25 million people worldwide which is the...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders